SCHEMBL29204835

SCHEMBL29204835

Cc1ccc(Cl)cc1N1CCN(c2ccc(C(=O)O)cc2NC(=O)c2ccc(C(F)(F)F)cc2)CC1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XPO1 O14980 4/20 0.74
TP53 P04637 3/20 0.54
GAA P10253 2/20 0.54
MAPT P10636 3/20 0.52
SRPK1 Q96SB4 2/20 0.51
KDR P35968 1/20 0.51
SRPK2 P78362 1/20 0.51
SRPK3 Q9UPE1 1/20 0.51
PPARG P37231 2/20 0.50
PPARD Q03181 2/20 0.50
NR1H4 Q96RI1 2/20 0.50
PPARA Q07869 1/20 0.50
ALDH1A1 P00352 2/20 0.49
IDH2 P48735 1/20 0.49
LMNA P02545 1/20 0.49
POLB P06746 1/20 0.48
HTT P42858 1/20 0.47
MCL1 Q07820 1/20 0.47
MEN1 O00255 1/20 0.47
TSHR P16473 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29204842 0.94 XPO1 (0.80) XPO1TP53GAAMAPTSRPK1
SCHEMBL29204805 0.92 XPO1 (0.88) XPO1TP53MAPTALDH1A1IDH2
SCHEMBL30883146 0.92 XPO1 (0.88) XPO1TP53MAPTALDH1A1IDH2
SCHEMBL29204824 0.90 XPO1 (0.61) XPO1TP53GAAMAPTSRPK1
SCHEMBL29204831 0.88 XPO1 (0.77) XPO1TP53MAPTALDH1A1IDH2
SCHEMBL30883139 0.88 XPO1 (0.77) XPO1TP53MAPTALDH1A1IDH2
SCHEMBL29204833 0.85 XPO1 (1.00) XPO1TP53MAPTALDH1A1IDH2
SCHEMBL30883142 0.85 XPO1 (1.00) XPO1TP53MAPTALDH1A1IDH2
SCHEMBL29204841 0.84 XPO1 (0.66) XPO1TP53GAAMAPTALDH1A1
SCHEMBL29204840 0.83 XPO1 (1.00) XPO1TP53GAAMAPTSRPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117964578-A Non-covalent CRM1 inhibitor and preparation method and application thereof 四川大学 2024-05-03 CN disclosed